Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




New Class of Stem Cell-Like Cells Offers Possibilities for Spinal Cord Repair

By LabMedica International staff writers
Posted on 19 Oct 2011
A collaborative study using a spinal cord atlas has found previously overlooked cell type, which may have implications for treating spinal cord injury and disease.

The Allen Institute for Brain Science (Seattle, WA, USA) announced September 15, 2011, the discovery of a new class of cells in the spinal cord that act like neural stem cells, offering a fresh avenue in the search for therapies to treat spinal cord injury and disease. More...
The published collaborative study, authored by scientists from the University of British Columbia (Vancouver, BC, Canada) , the Allen Institute for Brain Science, the Montreal Neurological Institute (Canada), and the Hospital at McGill University (Montreal, Canada), was published in September 2011 in the open access journal PLoS One.

The research team utilized the Allen Spinal Cord Atlas, a finely detailed genome-wide map of gene expression throughout the mouse spinal cord, to compare the genes expressed, or turned on, in adult spinal cord radial glia with those found in other neural stem cells, revealing a signature set of 122 genes that indicate the likeness of these cells to classic neural stem cells.

The nervous system has generally been thought to be incapable of repairing itself because the cells used to create it are exhausted during development. With the identification of these new stem cell-like radial glial cells, it may be possible to activate a specific set of genes in order to encourage those cells to reconstruct a damaged network in the adult spinal cord.

“By using the Allen Spinal Cord Atlas, we were able to discover a brand-new cell type that has previously been overlooked and that could be an important player in all manner of spinal cord injury and disease, including multiple sclerosis and ALS,” said Jane Roskams, PhD, neuroscientist at the University of British Columbia and senior author of the study.

From disabled veterans to those afflicted with Lou Gehrig’s disease, also known as amyotrophic lateral sclerosis (ALS) or spinal muscular atrophy, spinal cord-related diseases and disorders affect people of all ages, including nearly one-quarter of a million people in the United States who have suffered from a spinal cord injury; as many as 30,000 Americans who suffer from ALS at any given time; and approximately 2.5 million people worldwide who suffer from multiple sclerosis.

“This is a tremendous example of how our public atlas resources can lead to critical discoveries that offer promising avenues for developing much needed new clinical therapies,” said Allan Jones, PhD, chief executive officer of the Allen Institute.

Dr. Roskams, who led the collaborative research team, has reported that it is possible this pool of cells was overlooked because of its unusual location, and because scientists have been working with limited information. With the availability of the public, online Allen Spinal Cord Atlas, the information accessible to researchers has been vastly increased.

In the hunt for neural stem cells, scientists have been using a few known genes as clues to find candidates deep in the middle of the spinal cord. While some neural stem cells have been discovered there, the newly identified class of spinal cord radial glia run along the edge of the spinal cord, an incredibly convenient location for activating them with minimal secondary damage to help the spinal cord repair during disease or after injury.

“When we first saw known neural stem cell genes appearing in these cells on the edge of the cord, I realized we not only had a brand new cell, but had the capacity to reveal a new gene set that may also guide us to hidden neural stem cells in atypical locations in the brain. I did not expect so many of them to link to human diseases,” Dr. Roskams said.

Identifying these cells and the genes relevant to activate them opens fresh new pathways to explore effective therapies to treat spinal cord injury and several types of neurodegenerative disease. The Allen Spinal Cord Atlas, part of the suite of Allen Brain Atlas resources, is freely available online (please see Related Links below).

The Allen Institute for Brain Science is an independent, nonprofit medical research organization dedicated to accelerating understanding of the human brain by driving discovery for the broader scientific community. Through a product-focused approach, the Allen Institute generates innovative public resources used by researchers and organizations worldwide.

Related Links:
Allen Institute for Brain Science
University of British Columbia
Allen Spinal Cord Atlas




Gold Member
Blood Gas Analyzer
Stat Profile pHOx
POC Helicobacter Pylori Test Kit
Hepy Urease Test
CBM Analyzer
Complete Blood Morphology (CBM) Analyzer
Silver Member
PCR Plates
Diamond Shell PCR Plates
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.